By week ten, mice with ARK1-luc-dox-shUCHL1 tumors had significantly lower fold change increase in bioluminescence from week 2 ( Figure 2 E,F), and showed a trend towards improved overall survival ( Figure S2H ).
← all excerpts
Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.
1
—
—